These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8592137)

  • 1. Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release.
    Dluzen DE; McDermott JL; Liu B
    J Neurochem; 1996 Feb; 66(2):658-66. PubMed ID: 8592137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Dluzen D; Jain R; Liu B
    J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.
    Dluzen DE; McDermott JL; Liu B
    Neurotoxicol Teratol; 1996; 18(5):603-6. PubMed ID: 8888025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
    Miller DB; Ali SF; O'Callaghan JP; Laws SC
    Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
    Callier S; Morissette M; Grandbois M; Di Paolo T
    Synapse; 2000 Sep; 37(4):245-51. PubMed ID: 10891861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
    Dluzen DE
    Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Neuroscience; 2001; 103(2):385-94. PubMed ID: 11246153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.
    Dluzen D
    Brain Res; 1997 Sep; 767(2):340-4. PubMed ID: 9367266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
    Obuchowicz E; Antkiewicz-Michaluk L; Romańska I; Herman ZS
    J Neural Transm (Vienna); 2003 Dec; 110(12):1375-91. PubMed ID: 14666410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
    Khan HA
    Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
    Morissette M; Jourdain S; Al Sweidi S; Menniti FS; Ramirez AD; Di Paolo T
    Neuropharmacology; 2007 Jun; 52(7):1509-20. PubMed ID: 17420033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity.
    Fornai F; Battaglia G; Gesi M; Giorgi FS; Orzi F; Nicoletti F; Ruggieri S
    Brain Res; 2000 Dec; 887(1):110-7. PubMed ID: 11134595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomolar L-dopa facilitates release of dopamine via presynaptic beta-adrenoceptors: comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Parkinson's disease.
    Goshima Y; Misu Y; Arai N; Misugi K
    Jpn J Pharmacol; 1991 Jan; 55(1):93-100. PubMed ID: 1645816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.
    Dluzen DE; Liu B
    J Neural Transm Gen Sect; 1994; 95(3):209-22. PubMed ID: 7865176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.